Electrocardiographic alterations in patients treated for acute Lassa Fever: Description of results from a phase II clinical trial in Nigeria

Electrocardiographic alterations in patients treated for acute Lassa Fever: Description of results from a phase II clinical trial in Nigeria

Background: Lassa virus (LASV) leads to high case fatality among hospitalized patients in West Africa. While the pathophysiology of the disease is poorly understood, cardiac pathology is suspected to constitute an important feature of severe Lassa Fever (LF). We report an analysis of electrocardiogr...

Full description

Saved in:
Bibliographic Details
Main Authors: Cyril Erameh, Oladele Oluwafemi Ayodeji, Augusto Meneguim, Kevin Okwaraeke, Osahogie Edeawe, Enomen Ekata, ThankGod Akhigbe, Nelson Adedosu, Chukwuyem Abejegah, Sampson Owhin, Liasu Ahmed, Till Omansen, Meike Pahlmann, Georg Goliasch, Alexandre Duvignaud, Peter Akhideno, Sylvanus Okogbenin, Stephan Günther, Marie Jaspard, Michael Ramharter, Mirjam Groger
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:Journal of Infection and Public Health
Subjects:
Lassa fever
Viral hemorrhagic fever
Electrocardiography
Favipiravir
Ribavirin
Online Access:http://www.sciencedirect.com/science/article/pii/S1876034125002072
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S1876034125002072

Similar Items